|
|||||
|
|
Two engineered site-specific antibody-drug conjugates,HLmD4 and HLvM4, have potent therapeutic activity in two DLL4-positive tumour xenograft models |
|
| Authors: | Shijing Wang Hui Wen Wenyi Fei Yuhong Zhao Yuqi Feng Lu Kuang Min Wang Min Wu |
| Affiliation: | State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China |
| Abstract: | |
| Keywords: | |